3613.HK Beijing Tong Ren Tang Chinese Medicine Company Limited
HKSEHealthcareAs of 2026-08-28 16:08
Why 3613.HK matters now
Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK) is a Hong Kong stock in Healthcare. The latest InvestLog snapshot shows HK$6.50 with -0.31% on the session and HK$5.44B in market capitalization.
Valuation context is available even where detailed statement rows are sparse: InvestLog currently shows P/E 13.71, gross margin 61.2%, and operating margin 31.2%.
InvestLog's latest related AI research is a Earnings Release note titled "Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK) 2026 H1 financial results".
Valuation
P/E (TTM)
13.71
PEG
—
P/B
1.30
P/S
3.60
EV/EBITDA
6.74
DCF Value
—
FCF Yield
17.7%
Div Yield
6.2%
Margins & Returns
Gross Margin
61.2%
Operating Margin
31.2%
Net Margin
26.2%
ROE
9.7%
ROA
8.5%
ROIC
8.7%
Listing Info
Market
Hong Kong
Exchange
HKSE
Currency
HKD
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Country
HK
Beijing Tong Ren Tang Chinese Medicine Company Limited, encompassing its various affiliates, specializes in the production, distribution, and direct sale of traditional Chinese medicine and wellness items, catering to both corporate distributors and individual consumers. Its operations are geographically segmented across Hong Kong, Mainland China, and international markets. Additionally, the company provides traditional Chinese medical consultations and therapeutic services. The firm maintains a network of 23 retail stores throughout Hong Kong, complemented by 46 international outlets located across Asia, Oceania, North America, and Europe. All its offerings are sold under the well-recognized Tong Ren Tang brand. Established in 1669, the company's main office is situated in Wan Chai, Hong Kong.